Literature DB >> 24122405

Orphan symptoms in advanced cancer patients followed at home.

Sebastiano Mercadante1, Giampiero Porzio, Alessandro Valle, Flavio Fusco, Federica Aielli, Claudio Adile, Alessandra Casuccio.   

Abstract

Orphan symptoms are rarely assessed, particularly at home. The aim of this multicenter prospective study was to assess the prevalence of these symptoms and eventual factors possibly associated in advanced cancer patients at admission of a home care program. A prospective study was performed at three home care programs in Italy. Patients' data were collected, including age, sex, diagnosis, and Karnofsky status. Possible contributing factors were analyzed; preexisting neurological diseases, cerebral metastases, hyperthermia, diabetes, a state of dehydration clinically evident and/or oliguria, possible biochemical parameters when available, data regarding recent chemotherapy, opioids and doses, use of neuroleptics, benzodiazepine or anticonvulsants, corticosteroids, anti-inflammatory, and antibiotics were collected. Myoclonus, hiccup, sweating, pruritus, and tenesmus, either rectal or vesical, were assessed, according to a preliminary definition, at time of home care program admission. Three hundred sixty-two patients were surveyed at the three home care programs. Globally, 48 patients presented one or more orphan symptoms in the period taken into consideration, and 7 patients presented more than 1 symptom. One patient presented occasional and diffuse myoclonus. Nineteen patients presented sweating, 13 patients presented pruritus, and 14 patients presented hiccup. Finally, nine patients presented rectal or vesical tenesmus. There was a significant correlation between sweating and transdermal fentanyl use (P = 0.044), fever (P = 0.001), hiccup (P < 0.0005), and vesical tenesmus (P = 0.028). Pruritus was not associated to any factor. Hiccup was associated with gender (males, P = 0.006) and sweating (P < 0.0005). Vesical tenesmus was associated with fever (P = 0.019) and sweating (P = 0.028). Although the symptoms examined have a low prevalence in advanced cancer patients admitted to home care, the distress for patients may be high and deserve further analyses. Given the low prevalence of these symptoms, large studies are needed to find possible associated factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24122405     DOI: 10.1007/s00520-013-2007-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  13 in total

1.  Quality improvement in cancer symptom assessment and control: the Provincial Palliative Care Integration Project (PPCIP).

Authors:  Julie E Gilbert; Doris Howell; Susan King; Carol Sawka; Erin Hughes; Helen Angus; Deborah Dudgeon
Journal:  J Pain Symptom Manage       Date:  2012-04       Impact factor: 3.612

Review 2.  Treatment of chronic hiccups in cancer patients: a systematic review.

Authors:  Agnès Calsina-Berna; Garbiñe García-Gómez; Jesús González-Barboteo; Josep Porta-Sales
Journal:  J Palliat Med       Date:  2012-08-14       Impact factor: 2.947

Review 3.  The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991--2006).

Authors:  Cheryl Nekolaichuk; Sharon Watanabe; Crystal Beaumont
Journal:  Palliat Med       Date:  2008-03       Impact factor: 4.762

4.  Pruritus in palliative care: Getting up to scratch.

Authors:  Dori Seccareccia; Nadine Gebara
Journal:  Can Fam Physician       Date:  2011-09       Impact factor: 3.275

5.  Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: a pilot study.

Authors:  Shawn McCann; Tony L Yaksh; Charles F von Gunten
Journal:  J Opioid Manag       Date:  2010 Mar-Apr

6.  The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients.

Authors:  E Bruera; N Kuehn; M J Miller; P Selmser; K Macmillan
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

Review 7.  Pathophysiology and treatment of opioid-related myoclonus in cancer patients.

Authors:  S Mercadante
Journal:  Pain       Date:  1998-01       Impact factor: 6.961

Review 8.  Diagnosis and management of hiccups in the patient with advanced cancer.

Authors:  Mark A Marinella
Journal:  J Support Oncol       Date:  2009 Jul-Aug

9.  Myoclonus associated with high-dose parenteral methadone.

Authors:  Shiho Ito; Solomon Liao
Journal:  J Palliat Med       Date:  2008-07       Impact factor: 2.947

10.  A review of the reliability and validity of the Edmonton Symptom Assessment System.

Authors:  L A Richardson; G W Jones
Journal:  Curr Oncol       Date:  2009-01       Impact factor: 3.677

View more
  2 in total

Review 1.  Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups.

Authors:  Katharine Hendrix; David Wilson; M J Kievman; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

2.  Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment.

Authors:  D Santini; G Armento; R Giusti; M Ferrara; C Moro; F Fulfaro; P Bossi; F Arena; C I Ripamonti
Journal:  ESMO Open       Date:  2020-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.